表紙
市場調查報告書

全球蛋白質表現市場預測(∼2029年):無細胞表現系統,原核細胞/細菌表現系統,酵母細胞表現系統,藻類表現系統,昆蟲細胞表現系統,哺乳動物細胞表現系統

Global Protein Expression Market Forecast to 2029: Cell-free Expression System, Prokaryotic/Bacterial Expression System, Yeast Cell Expression Systems, Algal-based Expression Systems, Insect Cell Expression Systems, Mammalian Cell Expression Systems

出版商 Visiongain Ltd 商品編碼 917796
出版日期 內容資訊 英文 201 Pages
商品交期: 最快1-2個工作天內
價格
全球蛋白質表現市場預測(∼2029年):無細胞表現系統,原核細胞/細菌表現系統,酵母細胞表現系統,藻類表現系統,昆蟲細胞表現系統,哺乳動物細胞表現系統 Global Protein Expression Market Forecast to 2029: Cell-free Expression System, Prokaryotic/Bacterial Expression System, Yeast Cell Expression Systems, Algal-based Expression Systems, Insect Cell Expression Systems, Mammalian Cell Expression Systems
出版日期: 2019年10月24日內容資訊: 英文 201 Pages
簡介

全球蛋白質表現市場2018年為18億美元的規模。原核細胞表現系統佔全球40%市場。

本報告提供全球蛋白質表現市場相關調查,市場趨勢與預測,市場規模,主要加入企業,各地區趨勢相關資訊。

第1章 報告書概要

第2章 簡介

  • 細菌蛋白質表現系統
  • 酵母蛋白質表現系統
  • 桿狀病毒、昆蟲細胞蛋白質表現系統
  • 哺乳動物蛋白質表現系統
  • 無細胞蛋白質表現系統
  • 醫藥品用蛋白質製做的平台
  • 蛋白質表現系統的優點與缺點

第3章 至2029年的全球蛋白質表現市場預測

  • 全球市場預測
  • 推動市場的要素
  • 阻礙市場的要素
  • 機會
  • 課題
  • 各類型預測
  • 各產品、服務預測
  • 各用途預測
  • 各終端用戶預測

第4章 主要市場

  • 全球市場的各地區明細
  • 各地區預測
  • 北美
  • 歐洲
  • 亞洲

第5章 主要企業

  • Agilent Technologies
  • Thermo Fisher Scientific Inc.
  • EMD Millipore
  • TaKaRa BIO株式會社
  • New England Biolabs Inc.
  • Bio-Rad Technologies
  • Oxford Expression Technologies Ltd
  • Promega Corporation
  • Qiagen NV

第6章 趨勢與未來發展預測

第7章 市場定性分析

  • SWOT分析
  • STEP分析

第8章 結論

附錄

目錄
Product Code: PHA0553

The global protein expression market is estimated at $1.8bn in 2018. Visiongain estimated that the prokaryotic expression system accounted for 40.0% of the global protein expression market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 201-page report you will receive 70 tables and 115 figures- all unavailable elsewhere.

The 201-page report provides clear detailed insight into the global protein expression market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

  • Global Protein Expression Market forecasts to 2029
  • Global Protein Expression Market forecasts to 2029 by Expression System:
  • Cell-free Expression System
  • Prokaryotic/ Bacterial Expression System
  • Yeast Cell Expression Systems
  • Algal-based Expression Systems
  • Insect Cell Expression Systems
  • Mammalian Cell Expression Systems

image1

  • Global Protein Expression Market forecasts to 2029 by Product & Services:
  • Reagents
  • Expression Vectors
  • Competent Cells
  • Instruments
  • Services
  • Global Protein Expression Market forecasts to 2029 by Application:
  • Therapeutic Applications
  • Industrial Application
  • Research Application
  • Global Protein Expression Market forecasts to 2029 by End-User:
  • Pharmaceutical and Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations (CROs)
  • Global Protein Expression Market forecasts to 2029 by National Market:
  • North America: US, Canada
  • EU: Germany, France, UK, Italy, Spain
  • Asia: Japan, China, India
  • Assessment of selected leading companies that hold major market shares in the protein expression industry:
  • Agilent Technologies
  • Bio-Rad Technologies
  • EMD Milipore
  • New England Biolabs, Inc.
  • Oxford Expression Technologies, Ltd.
  • Promega Corporation
  • Qiagen NV
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • Discussions on trends in the industry and assesses strengths and weaknesses, as well as opportunities and threats (SWOT). It also analyses social, technological, economic and political factors (STEP) that influence the protein expression market. Moreover, this report discusses factors that drive and restrain the protein expression market.
  • Key Questions Answered by This Report:
  • What is the current size of the protein expression market? How much will this market be worth from 2019-2029?
  • What will be the main drivers and restraints for this market?
  • What are the different segments of the protein expression market? How much will each of these segments be worth during 2019-2029 and how will their market shares change during this period?
  • What are the largest national protein expression markets? How much will these markets be worth from 2019-2029? How will the emerging markets affect the market shares of the mature markets?
  • What are the most prominent companies in the market? What products and services do they offer, and what are the main features and advantages of them?
  • What are the main trends affecting the market? What technologies will increase in prominence between 2019 and 2029? What are the advantages of these technologies?
  • What are the main strengths, weaknesses, opportunities and threats for the market? What are the social, technological, economic and political factors affecting the market?

Visiongain's study is intended for anyone requiring commercial analyses for the Global Protein Expression Market. You find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Protein Expression Overview
  • 1.2 Protein Expression Market Segmentation
  • 1.3 Why You Should Read This Report
  • 1.4 How This Report Delivers
  • 1.5 Questions Answered by this Report
  • 1.6 Who is this Report for?
  • 1.7 Research Methods and Analysis
  • 1.8 Frequently Asked Questions
  • 1.9 Associated Reports
  • 1.10 About Visiongain

2. Introduction to Protein Expression Systems and Applications

  • 2.1 Bacteria Protein Expression System
  • 2.2 Yeast Protein Expression System
    • 2.2.1 Kluyveromyces lactis Protein Expression System
    • 2.2.2 Pichia pastoris Protein Expression System
    • 2.2.3 Saccharomyces cerevisiae Protein Expression System
  • 2.3 Baculovirus-Insect Cells Protein Expression System
  • 2.4 Mammalian Protein Expression System
  • 2.5 Cell-Free Protein Expression System
  • 2.6 Platforms for production of pharmaceutical proteins
  • 2.7 Advantages and Disadvantages of Protein Expression Systems

3. World Protein Expression Market Forecast to 2029

  • 3.1 Global Protein Expression Market Forecast 2019-2029
  • 3.2 Drivers for the Protein Expression Market
    • 3.2.1 Growing incidence of chronic diseases
    • 3.2.2 Increasing R&D investment in biologics
    • 3.2.3 A platform of benefits
    • 3.2.4 Improving efficiency, yield, and functionality
  • 3.3 Restraints for the Protein Expression Market
    • 3.3.1 High cost of instruments
    • 3.3.2 Stringent Regulations and High Barriers for New Entrants
  • 3.4 Opportunities
    • 3.4.1 Microfluidic Devices for Drug Delivery Systems and Drug Screening
    • 3.4.2 Emerging countries to offer lucrative growth opportunities
    • 3.4.3 Rising Demand for Proteins in Drugs Development
    • 3.4.4 Promising Developments in Protein Expression
  • 3.5 Challenges
    • 3.5.1 Contamination - A Major Challenge in Protein Purification
    • 3.5.2 Overcoming cellular complexity
  • 3.6 Global Protein Expression Market by Expression System Type: Forecasts 2019-2029
    • 3.6.1 Cell-free Expression System Segment Forecasts 2019-2029
    • 3.6.2 Prokaryotic/ Bacterial Expression System Segment Forecasts 2019-2029
    • 3.6.3 Escherichia coli Bacterial Protein Expression System
    • 3.6.4 Yeast Cell Expression System Segment Forecasts 2019-2029
      • 3.6.4.1 Kluyveromyces lactis (K. lactis) Systems
      • 3.6.4.2 Saccharomyces Systems
      • 3.6.4.3 Pichia Systems
    • 3.6.5 Algal-based Expression Systems
    • 3.6.6 Insect Cell Expression Systems
      • 3.6.6.1 Baculovirus Systems
    • 3.6.7 Mammalian Cell Expression Systems
      • 3.6.7.1 Chinese Hamster Ovary (CHO) Systems
  • 3.7 Global Protein Expression Market by Product & Services: Forecasts 2019-2029
    • 3.7.1 Reagents Segment Forecasts 2019-2029
    • 3.7.2 Expression Vectors Segment Forecasts 2019-2029
    • 3.7.3 Competent Cells Segment Forecasts 2019-2029
    • 3.7.4 Instruments Segment Forecasts 2019-2029
    • 3.7.5 Services Segment Forecasts 2019-2029
  • 3.8 Global Protein Expression Market by Application: Forecasts 2019-2029
    • 3.8.1 Therapeutic Application Forecasts 2019-2029
    • 3.8.2 Industrial Application Forecasts 2019-2029
    • 3.8.3 Research Application Forecasts 2019-2029
  • 3.9 Global Protein Expression Market by End-User: Forecasts 2019-2029
    • 3.9.1 Pharma & Biotech Companies Forecasts 2019-2029
    • 3.9.2 Academic Institutions Forecasts 2019-2029
    • 3.9.3 Contract Research Organizations (CROs) Forecasts 2019-2029

4. Leading National Markets for Protein Expression, 2019-2029

  • 4.1 Regional Breakdown of the Global Protein Expression Market, 2019-2029
  • 4.2 Global Protein Expression Market: Regional Forecast 2019-2029
  • 4.3 North America Protein Expression Revenue Forecast 2019-2029
    • 4.3.1 The US Protein Expression Revenue Forecast 2019-2029
    • 4.3.2 Canada Protein Expression Revenue Forecast 2019-2029
  • 4.4 European Union (EU) Protein Expression Market 2019-2029
    • 4.4.1 Drug Discovery Platform in Europe holds Much Promise
    • 4.4.2 EU National Market Share Breakdown, 2019, 2024 and 2029
    • 4.4.3 EU Market: Main National Forecasts, 2019-2029
    • 4.4.4 German Protein Expression Revenue Forecast, 2019-2029
    • 4.4.5 UK Protein Expression Revenue Forecast, 2019-2029
    • 4.4.6 French Protein Expression Revenue Forecast, 2019-2029
    • 4.4.7 Spanish Protein Expression Revenue Forecast, 2019-2029
    • 4.4.8 Italian Protein Expression Revenue Forecast, 2019-2029
  • 4.5 Asia (Japan, China and India) Protein Expression Market 2019-2029
    • 4.5.1 Asia Countries National Breakdown, 2019, 2024 and 2029
    • 4.5.2 Asia Market: Main National Forecasts, 2019-2029
    • 4.5.3 Japanese Protein Expression Revenue Forecast, 2019-2029
    • 4.5.4 Chinese Protein Expression Revenue Forecast, 2019-2029
    • 4.5.5 Indian Protein Expression Revenue Forecast, 2019-2029

5. Leading Companies in the Protein Expression Market, 2018

  • 5.1 Agilent Technologies
    • 5.1.1 Business Overview
    • 5.1.2 Company Snapshot
    • 5.1.3 Agilent Technologies, Inc.: Protein Expression Product Portfolio
    • 5.1.4 Agilent Technologies, Inc.: Financial Overview
    • 5.1.5 Agilent Technologies, Inc.: Recent Developments
  • 5.2 Thermo Fisher Scientific Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Company Snapshot
    • 5.2.3 Thermo Fisher Scientific: Protein Expression Product Portfolio
    • 5.2.4 Thermo Fisher Scientific: Financial Overview
    • 5.2.5 Thermo Fisher Scientific: Recent Developments
  • 5.3 EMD Millipore
    • 5.3.1 Business Overview
    • 5.3.2 Company Snapshot
    • 5.3.3 EMD Millipore: Protein Expression Product Portfolio
    • 5.3.4 EMD Millipore: Financial Overview
    • 5.3.5 EMD Millipore: Recent Developments
  • 5.4 Takara Bio, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Company Snapshot
    • 5.4.3 Takara Bio, Inc.: Protein Expression Product Portfolio
    • 5.4.4 Takara Bio, Inc.: Financial Overview
    • 5.4.5 Takara Bio, Inc.: Recent Developments
  • 5.5 New England Biolabs Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Company Snapshot
    • 5.5.3 New England Biolabs, Inc.: Protein Expression Product Portfolio
    • 5.5.4 New England Biolabs, Inc.: Financial Overview
    • 5.5.5 New England Biolabs, Inc.: Recent Developments
  • 5.6 Bio-Rad Technologies
    • 5.6.1 Business Overview
    • 5.6.2 Company Snapshot
    • 5.6.3 Bio-Rad Technologies: Protein Expression Product Portfolio
    • 5.6.4 Bio-Rad Technologies: Financial Overview
    • 5.6.5 Bio-Rad Technologies: Recent Developments
  • 5.7 Oxford Expression Technologies Ltd
    • 5.7.1 Business Overview
    • 5.7.2 Company Snapshot
    • 5.7.3 Oxford Expression Technologies Ltd: Protein Expression Product Portfolio
    • 5.7.4 Oxford Expression Technologies Ltd: Financial Overview
    • 5.7.5 Oxford Expression Technologies Ltd: Recent Developments
  • 5.8 Promega Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Company Snapshot
    • 5.8.3 Promega Corporation: Protein Expression Product Portfolio
    • 5.8.4 Promega Corporation: Financial Overview
  • 5.9 Qiagen NV
    • 5.9.1 Business Overview
    • 5.9.2 Company Snapshot
    • 5.9.3 Qiagen NV: Protein Expression Product Portfolio
    • 5.9.4 Qiagen NV: Financial Overview
    • 5.9.5 Qiagen NV: Recent Developments

6. Protein Expression, Trends and Future Outlook

  • 6.1 Pharmaceutical protein production
  • 6.2 Engineering of biopharmaceuticals
    • 6.2.1 Glycoengineering
    • 6.2.2 PEGylation
  • 6.3 Incorporation of unnatural amino acids
  • 6.4 GPCRs: A Common Drug and Drug Discovery Target
    • 6.4.1 Allosteric GPCRs
  • 6.5 Protein Expression for the Development of Biologics
  • 6.6 Future outlook

7. Qualitative Analysis of the Protein Expression Market, 2018

  • 7.1 SWOT Analysis of the Protein Expression Market
    • 7.1.1 Strengths Within the Protein Expression Market
    • 7.1.2 Weaknesses Within the Protein Expression Market
    • 7.1.3 Opportunities for the Protein Expression Market
    • 7.1.4 Threats to the Protein Expression Market
  • 7.2 STEP Analysis of the Protein Expression Market
    • 7.2.1 Social Factors
    • 7.2.2 Technological Factors
    • 7.2.3 Economic Factors
    • 7.2.4 Political Factors

8. Conclusions from the Research and Analysis

  • 8.1 Growth Has Been Driven by Advantages of Protein Expression Systems
  • 8.2 Current Status of the Market and its Growth Drivers
  • 8.3 The Most Dominant National Markets and Emerging Countries

Appendices

  • Associated Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Report Evaluation Form

List of Tables

  • Table 3.1 Global Protein Expression Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2019-2029
  • Table 3.2 Global Protein Expression Market Forecast by Expression Type: Revenues ($m), AGR (%) and CAGR (%), 2019-2029
  • Table 3.3 Cell-Free Protein Expression System Forecast: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2019-2029
  • Table 3.4 Prokaryotic/ Bacteria Protein Expression System Forecast: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2019-2029
  • Table 3.5 E. Coli Expression System Forecast: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2019-2029
  • Table 3.6 Yeast Protein Expression System Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2019-2029
  • Table 3.7 Kluyveromyces lactis Expression System Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2019-2029
  • Table 3.8 Saccharomyces Expression System Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2019-2029
  • Table 3.9 Pichia Expression System Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2019-2029
  • Table 3.10 Algal Based Protein Expression System Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2019-2029
  • Table 3.11 Insect Cell Protein Expression System Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2019-2029
  • Table 3.12 Baculovirus Expression System Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2019-2029
  • Table 3.13 Mammalian Cell Protein Expression System Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2019-2029
  • Table 3.14 Chinese Hamster Ovary (CHO) Expression System Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2019-2029
  • Table 3.15 Global Protein Expression Market Forecast by Products & Services: Revenues ($m), AGR (%) and CAGR (%), 2019-2029
  • Table 3.16 Reagents Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2019-2029
  • Table 3.17 Expression Vectors Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2019-2029
  • Table 3.18 Competent Cells Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2019-2029
  • Table 3.19 Instruments Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2019-2029
  • Table 3.20 Services Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2019-2029
  • Table 3.21 Global Protein Expression Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2019-2029
  • Table 3.22 Therapeutic Application Segment Forecast: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2019-2029
  • Table 3.23 Industrial Application Segment Forecast: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2019-2029
  • Table 3.24 Research Application Segment Forecast: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2019-2029
  • Table 3.25 Protein Expression Market End-Users Forecasts: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2019-2029
  • Table 3.26 Pharma & Biotech Companies Forecast: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2019-2029
  • Table 3.27 Academic Institutes Forecast: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2019-2029
  • Table 3.28 CROs Forecast: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2019-2029
  • Table 4.1 Protein Expression Market Breakdown by Region: Revenues ($m), Market Shares (%), 2019
  • Table 4.2 Protein Expression Market Breakdown by Region: Revenues ($m), Market Shares (%), 2024
  • Table 4.3 Protein Expression Market Breakdown by Region: Revenues ($m), Market Shares (%), 2029
  • Table 4.4 Global Protein Expression Market Regional Forecasts: Revenues ($m), AGR (%), CAGR (%), Market Shares (%), 2019-2029
  • Table 4.5 North America Protein Expression Market Forecasts: Revenues ($m), AGR (%), CAGR (%), Market Shares (%), 2019-2029
  • Table 4.6 US Protein Expression Market Forecast: Revenues ($m), AGR (%), Market Shares (%), CAGR (%), 2019-2029
  • Table 4.7 Canada Protein Expression Market Forecast: Revenues ($m), AGR (%), Market Shares (%), CAGR (%), 2019-2029
  • Table 4.8 EU Protein Expression Market Forecast: Revenues ($m), AGR (%), World Market Shares (%), CAGR (%), 2019-2029
  • Table 4.9 EU Market Breakdown by Leading Nation: EU Market Shares (%), Global Market Shares (%) and Revenues ($m), 2019
  • Table 4.10 EU Market Breakdown by Leading Nation: EU Market Shares (%), Global Market Shares (%) and Revenues ($m), 2024
  • Table 4.11 EU Market Breakdown by Leading Nation: EU Market Shares (%), Global Market Shares (%) and Revenues ($m), 2029
  • Table 4.12 EU Market, Leading National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2019-2029
  • Table 4.13 German Protein Expression Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2019-2029
  • Table 4.14 UK Protein Expression Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2019-2029
  • Table 4.15 French Protein Expression Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2019-2029
  • Table 4.16 Spanish Protein Expression Market Forecast: Revenues ($m), 2019-2029
  • Table 4.17 Italian Protein Expression Market Forecast: Revenues ($m), 2019-2029
  • Table 4.18 Asia Market Breakdown by Nation: Asia market Shares (%), Global Market Shares (%) and Revenues ($m), 2019
  • Table 4.19 Asia Market Breakdown by Nation: Asia market Shares (%), Global Market Shares (%) and Revenues ($m), 2024
  • Table 4.20 Asia Market Breakdown by Nation: Asia market Shares (%), Global Market Shares (%) and Revenues ($m), 2029
  • Table 4.21 Asia National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2019-2029
  • Table 4.22 Japanese Protein Expression Market Forecast: Revenues ($m), 2019-2029
  • Table 4.23 Chinese National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2019-2029
  • Table 4.24 Indian National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2019-2029
  • Table 5.1 Agilent Technologies, Inc.: Company Profile
  • Table 5.2 Agilent Technologies, Inc.: Protein Expression Product Portfolio
  • Table 5.3 Thermo Fisher Scientific, Inc.: Company Profile
  • Table 5.4 Thermo Fisher Scientific, Inc.: Protein Expression Product Portfolio
  • Table 5.5 EMD Millipore: Company Profile
  • Table 5.6 EMD Millipore: Protein Expression Product Portfolio
  • Table 5.7 Takara Bio Inc.: Company Profile
  • Table 5.8 Takara Bio Inc.: Protein Expression Product Portfolio
  • Table 5.9 New England Biolabs, Inc.: Company Profile
  • Table 5.10 New England Biolabs, Inc.: Protein Expression Product Portfolio
  • Table 5.11 Bio-Rad Laboratories, Inc.: Company Profile
  • Table 5.12 Bio-Rad Laboratories, Inc.: Protein Expression Product Portfolio
  • Table 5.13 Oxford Expression Technologies Ltd: Company Profile
  • Table 5.14 Oxford Expression Technologies Ltd: Protein Expression Product Portfolio
  • Table 5.15 Promega Corporation: Company Profile
  • Table 5.16 Promega Corporation: Protein Expression System Product Portfolio
  • Table 5.17 Qiagen NV: Company Profile
  • Table 5.18 Qiagen NV: Protein Expression Product Portfolio

List of Figures

  • Figure 1.1 Protein Expression Market Segmented by System Type
  • Figure 1.2 Protein Expression Market Segmented by Product & Services
  • Figure 1.3 Protein Expression Market Segmented by Application
  • Figure 1.4 Protein Expression Market Segmented by End-User
  • Figure 3.1 Global Protein Expression Market Forecast: Revenue ($m), 2019-2029
  • Figure 3.2 Estimated number of new lung cancer cases worldwide, 2012-2030
  • Figure 3.3 Estimated number of new pancreatic cancer cases worldwide, 2012-2030
  • Figure 3.4 R&D investment of phRMA members between 2011 and 2015
  • Figure 3.5 Global Protein Expression Market Forecast by Expression Type: Revenue ($m), 2019-2029
  • Figure 3.6 Cell-Free Protein Expression System Forecast: Revenue ($m), 2019-2029
  • Figure 3.7 Cell-Free Protein Expression System Forecast: AGR (%), 2019-2029
  • Figure 3.8 Prokaryotic/ Bacteria Protein Expression System Forecast: Revenue ($m), 2019-2029
  • Figure 3.9 Prokaryotic/ Bacteria Protein Expression System Forecast: AGR (%), 2019-2029
  • Figure 3.10 E. Coli Expression System Forecast - Revenue ($m), 2019-2029
  • Figure 3.11 E. Coli Expression System Forecast -AGR (%), 2019-2029
  • Figure 3.12 Yeast Protein Expression System Forecast - Revenue ($m), 2019-2029
  • Figure 3.13 Yeast Protein Expression System Forecast -AGR (%), 2019-2029
  • Figure 3.14 Kluyveromyces lactis Expression System Forecast - Revenue ($m), 2019-2029
  • Figure 3.15 Kluyveromyces lactis Expression System Forecast - AGR (%), 2019-2029
  • Figure 3.16 Saccharomyces Expression System Forecast - Revenue ($m), 2019-2029
  • Figure 3.17 Saccharomyces Expression System Forecast - AGR (%), 2019-2029
  • Figure 3.18 Pichia Expression System Forecast - Revenue ($m), 2019-2029
  • Figure 3.19 Yeast Protein Expression Market Segments: Pichia Expression System Forecast - AGR (%), 2019-2029
  • Figure 3.20 Algal Based Protein Expression System Forecast - Revenue ($m), 2019-2029
  • Figure 3.21 Protein Expression Market Segments: Algal Based Protein Expression System Forecast -AGR (%), 2019-2029
  • Figure 3.22 Insect Cell Protein Expression System Forecast - Revenue ($m), 2019-2029
  • Figure 3.23 Insect Cell Protein Expression System Forecast -AGR (%), 2019-2029
  • Figure 3.24 Baculovirus Expression System Forecast - Revenue ($m), 2019-2029
  • Figure 3.25 Baculovirus Expression System Forecast - AGR (%), 2019-2029
  • Figure 3.26 Mammalian Cell Protein Expression System Forecast - Revenue ($m), 2019-2029
  • Figure 3.27 Mammalian Cell Protein Expression System Forecast -AGR (%), 2019-2029
  • Figure 3.28 Chinese Hamster Ovary (CHO) Expression System Forecast - Revenue ($m), 2019-2029
  • Figure 3.29 Chinese Hamster Ovary (CHO) Expression System Forecast - AGR (%), 2019-2029
  • Figure 3.30 Global Protein Expression Market Forecast by Products & Services: Revenue ($m), 2019-2029
  • Figure 3.31 Protein Expression Market Segments: Reagents Forecast - Revenue ($m), 2019-2029
  • Figure 3.32 Protein Market Segments: Reagents Forecast -AGR (%), 2019-2029
  • Figure 3.33 Expression Vectors Forecast - Revenue ($m), 2019-2029
  • Figure 3.34 Expression Vectors Forecast -AGR (%), 2019-2029
  • Figure 3.35 Protein Expression Market Segments: Competent Cells Forecast - Revenue ($m), 2019-2029
  • Figure 3.36 Protein Market Segments: Competent Cells Forecast -AGR (%), 2019-2029
  • Figure 3.37 Instruments Forecast - Revenue ($m), 2019-2029
  • Figure 3.38 Instruments Forecast -AGR (%), 2019-2029
  • Figure 3.39 Services Forecast - Revenue ($m), 2019-2029
  • Figure 3.40 Services Forecast -AGR (%), 2019-2029
  • Figure 3.41 Global Protein Expression Market Forecast by Application: Revenue ($m), 2019-2029
  • Figure 3.42 Therapeutic Application Segment Forecast: Revenue ($m), 2019-2029
  • Figure 3.43 Therapeutic Application Segment Forecast: AGR (%), 2019-2029
  • Figure 3.44 Industrial Application Segment Forecast: Revenue ($m), 2019-2029
  • Figure 3.45 Industrial Application Segment Forecast: AGR (%), 2019-2029
  • Figure 3.46 Research Application Segment Forecast: Revenue ($m), 2019-2029
  • Figure 3.47 Industrial Application Segment Forecast: AGR (%), 2019-2029
  • Figure 3.48 Protein Expression Market End-Users Forecasts: Revenue ($m), 2019-2029
  • Figure 3.49 Pharma & Biotech Companies Forecast: Revenue ($m), 2019-2029
  • Figure 3.50 Pharma & Biotech Companies Forecast: AGR (%), 2019-2029
  • Figure 3.51 Academic Institutes Forecast: Revenue ($m), 2019-2029
  • Figure 3.52 Academic Institutes Forecast: AGR (%), 2019-2029
  • Figure 3.53 CROs Forecast: Revenue ($m), 2019-2029
  • Figure 3.54 CROs Forecast: AGR (%), 2019-2029
  • Figure 4.1 Protein Expression Market Breakdown by Region: Market Shares (%), 2019
  • Figure 4.2 Protein Expression Market Breakdown by Region: Market Shares (%), 2024
  • Figure 4.3 Protein Expression Market Breakdown by Region: Market Shares (%), 2029
  • Figure 4.4 Global Protein Expression Market Regional Forecasts: Revenues ($m), 2019-2029
  • Figure 4.5 North America Protein Expression Market Regional Forecasts: Revenues ($m), 2019-2029
  • Figure 4.6 US Protein Expression Market Forecast: Revenues ($m), 2019-2029
  • Figure 4.7 US Protein Expression Market Forecast: AGR (%), 2019-2029
  • Figure 4.8 Canada Protein Expression Market Forecast: Revenues ($m), 2019-2029
  • Figure 4.9 Canada Protein Expression Market Forecast: AGR (%), 2019-2029
  • Figure 4.10 EU Protein Expression Market Forecast: Revenues ($m), 2019-2029
  • Figure 4.11 EU Protein Expression Market Forecast: AGR (%), 2019-2029
  • Figure 4.12 EU Market Breakdown by Nation: EU Market Shares (%), 2019
  • Figure 4.13 EU Market Breakdown by Nation: Market Shares (%), 2024
  • Figure 4.14 EU Market Breakdown by Nation: Market Shares (%), 2029
  • Figure 4.15 EU Market, Top National Forecasts: Revenue ($m), 2019-2029
  • Figure 4.16 German Protein Expression Market Forecast: Revenues ($m), 2019-2029
  • Figure 4.17 German Protein expression Market Forecast: AGR (%), 2019-2029
  • Figure 4.18 UK Protein Expression Market Forecast: Revenues ($m), 2019-2029
  • Figure 4.19 UK Protein Expression Market Forecast: AGR (%), 2019-2029
  • Figure 4.20 French Protein Expression Market Forecast: Revenues ($m), 2019-2029
  • Figure 4.21 French Protein Expression Market Forecast: AGR (%), 2019-2029
  • Figure 4.22 Spanish Protein Expression Market Forecast: Revenues ($m) 2019-2029
  • Figure 4.23 Spanish Protein Expression Market Forecast: AGR (%), 2019-2029
  • Figure 4.24 Italian Protein Expression Market Forecast: Revenues ($m), 2019-2029
  • Figure 4.25 Italian Protein Expression Market Forecast: AGR (%), 2019-2029
  • Figure 4.26 Asia Market Breakdown by Nation: Market Shares (%), 2019
  • Figure 4.27 Asia Market Breakdown by Nation: Market Shares (%), 2024
  • Figure 4.28 Asia Market Breakdown by Nation: Market Shares (%), 2029
  • Figure 4.29 Asia Countries Breakdown by Nation: Revenues ($m), 2019-2029
  • Figure 4.30 Japanese Protein Expression Market Forecast: Revenues ($m), 2019-2029
  • Figure 4.31 Japanese Protein Expression Market Forecast: AGR (%), 2019-2029
  • Figure 4.32 Chinese Protein Expression Market Forecast: Revenues ($m), 2019-2029
  • Figure 4.33 Chinese Protein Expression Market Forecast: AGR (%), 2019-2029
  • Figure 4.34 Indian Protein Expression Market Forecast: Revenue ($m), 2019-2029
  • Figure 4.35 Indian Protein Expression Market Forecast: AGR (%), 2019-2029
  • Figure 5.1 Agilent Technologies, Inc.: Net Revenues, 2016-2018 ($Million)
  • Figure 5.2 Agilent Technologies, Inc.: Net Revenue by Segment (%), 2018
  • Figure 5.3 Agilent Technologies, Inc.: Net Revenue by Geography (%), 2018
  • Figure 5.4 Thermo Fisher Scientific: Net Revenues, 2016-2018 ($Million)
  • Figure 5.5 Thermo Fisher Scientific: Net Revenue by Segment (%), 2018
  • Figure 5.6 Thermo Fisher Scientific: Net Revenue by Geography (%), 2018
  • Figure 5.7 Merck KGaA: Net Revenues, 2016-2018 ($Million)
  • Figure 5.8 Merck KGaA: Net Revenue by Segment (%), 2018
  • Figure 5.9 Merck KGaA: Net Revenue by Geography (%), 2018
  • Figure 5.10 Takara Bio Inc.: Net Revenues, 2018-2019 ($Million)
  • Figure 5.11 Takara Bio Inc.: Net Revenue by Segment (%), 2018
  • Figure 5.12 Takara Bio Inc.: Net Revenue by Geography (%), 2018
  • Figure 5.13 Bio-Rad Laboratories, Inc.: Net Revenues, 2016-2018 ($Million)
  • Figure 5.14 Bio-Rad Laboratories, Inc.: Net Revenue by Segment, 2018
  • Figure 5.15 Bio-Rad Laboratories, Inc.: Net Revenue by Geography, 2018
  • Figure 5.16 Qiagen NV: Net Revenues, 2016-2018 ($Million)
  • Figure 5.17 Qiagen NV: Net Revenue by Segment, 2018
  • Figure 5.18 Qiagen NV: Net Revenue by Geography, 2018
  • Figure 7.1 Strengths and Weaknesses of the Protein Expression Market
  • Figure 7.2 Opportunities and Threats of the Protein Expression Market
  • Figure 8.1 Regional Breakdown of the Protein Expression Market by Revenue ($m), 2019, 2024 and 2029

List of Companies and Organisations Mentioned in the Report

  • Abgenex
  • Agilent Technologies Inc.
  • Anthem Biosciences
  • AstraZeneca
  • Bayer
  • Bio-Rad Technologies
  • Biotechnology Industry Research Assistance Council
  • BioTek Instruments
  • Brammer Bio
  • Bristol-Myers Squibb
  • Cancer Research UK
  • Centers for Disease Control and Prevention
  • Clontech Laboratories, Inc.
  • Department of Biotechnology
  • EMD Millipore
  • GIMDx, Inc.
  • HD Biosciences Co., Ltd.
  • Icagen, Inc.
  • IncellDx, Inc
  • InnoCore Pharmaceuticals
  • InSphero AG
  • Institute for Molecular Medicine Finland
  • Janssen
  • Labcyte Inc.
  • Likarda
  • Luxcel Biosciences Ltd
  • Merck
  • Merck & Co., Inc
  • New England Biolabs Inc.
  • Novo Nordisk Foundation Center for Biosustainability
  • On Target Co., Ltd.
  • OriGene
  • Oxford Expression Technologies Ltd
  • Pharmaceutical Research and Manufacturers of America
  • Promega Corporation
  • Qiagen NV
  • Sanofi
  • SciGenom
  • Sigma-Aldrich Corporation
  • Sino Biologicals
  • Takara Bio Inc.
  • Takeda Pharmaceutical Company
  • Technical University of Denmark
  • Thermo Fisher Scientific Inc.
  • UCB
  • WaferGen Bio-systems, Inc.
  • World Health Organization